We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
112 hedge funds and large institutions have $89.7M invested in Puma Biotechnology in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
756% more call options, than puts
Call options by funds: $137K | Put options by funds: $16K
119% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 21
87% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 15
18% more capital invested
Capital invested by funds: $75.9M → $89.7M (+$13.8M)
12% more funds holding
Funds holding: 100 → 112 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.76% less ownership
Funds ownership: 60.63% → 59.88% (-0.76%)
Holders
112
Holders Change
+12
Holders Change %
+12%
% of All Funds
1.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
46
Reduced
21
Closed
15
Calls
$137K
Puts
$16K
Net Calls
+$121K
Net Calls Change
+$12K
Top Buyers
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$629K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$497K |
| 3 |
D.E. Shaw & Co
New York
|
+$481K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$444K |
| 5 |
Two Sigma Investments
New York
|
+$384K |
Top Sellers
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$7.81M |
| 2 |
Millennium Management
New York
|
-$2.87M |
| 3 |
EP
Eversept Partners
New York
|
-$865K |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$788K |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$638K |
